RescueFlow Stungulyf/innrennslislyf, lausn 60/75 g/l আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

rescueflow stungulyf/innrennslislyf, lausn 60/75 g/l

oresund pharma aps - dextran 70; sodium chloride - stungulyf/innrennslislyf, lausn - 60/75 g/l

Iasibon ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

iasibon

pharmathen s.a. - ibandrónsýra - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - lyf til að meðhöndla beinsjúkdóma - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. meðferð æxli völdum álíka með eða án meinvörp. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

Uniferon Stungulyf, lausn 200 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

uniferon stungulyf, lausn 200 mg/ml

pharmacosmos a/s* - ferri hydroxidum dextran komplex - stungulyf, lausn - 200 mg/ml

Flucloxacillin WH Stungulyfs-/innrennslisstofn, lausn 1000 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

flucloxacillin wh stungulyfs-/innrennslisstofn, lausn 1000 mg

williams & halls ehf.* - flucloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 1000 mg

Midazolam Accord Stungulyf/innrennslislyf, lausn 5 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

midazolam accord stungulyf/innrennslislyf, lausn 5 mg/ml

accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 5 mg/ml

Midazolam Accord Stungulyf/innrennslislyf, lausn 1 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

midazolam accord stungulyf/innrennslislyf, lausn 1 mg/ml

accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 1 mg/ml

Simulect ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

simulect

novartis europharm limited - basiliximab - graft rejection; kidney transplantation - Ónæmisbælandi lyf - simulect er ætlað til að fyrirbyggja bráðan líffæraútgáfu í nýsköpun á nýru í nýrum hjá fullorðnum og börnum (1-17 ára). Það er til þess að vera notuð samhliða með ciclosporin fyrir microemulsion - og barksteri byggir ónæmisbæling, í sjúklinga með spjaldið viðbrögð mótefni minna en 80%, eða þrefaldur viðhald ónæmisbælandi meðferð inniheldur ciclosporin fyrir microemulsion, krefur og annaðhvort azatíóprín eða mycofenolatmofetils.

Ondansetron Fresenius Kabi Stungulyf, lausn 2 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

ondansetron fresenius kabi stungulyf, lausn 2 mg/ml

fresenius kabi ab - ondansetronum hýdróklóríð - stungulyf, lausn - 2 mg/ml

Pemetrexed WH (Pemetrexed Synthon) Innrennslisþykkni, lausn 25 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

pemetrexed wh (pemetrexed synthon) innrennslisþykkni, lausn 25 mg/ml

williams & halls ehf. - pemetrexedum inn - innrennslisþykkni, lausn - 25 mg/ml

Doxorubicin medac Innrennslislyf, lausn 2 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

doxorubicin medac innrennslislyf, lausn 2 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - doxorubicinum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml